Vasoactive intestinal peptide regulates cholesterol side-chain cleavage cytochrome P-450 (P-450scc) gene expression in granulosa cells from immature rat ovaries. Trzeciak WH, Waterman MR, Simpson ER, Ojeda SR (1987) Mol Endocrinol 1: 500-4 CD4+ T cell-derived novel peptide Thp5 induces interleukin-4 production in CD4+ T cells to direct T helper 2 cell differentiation. Khan MM, Chatterjee S, Dwivedi VP, Pandey NK, Singh Y, Tousif S, Bhavesh NS, Van Kaer L, Das J, Das G (2012) J Biol Chem 287: 2830-5 Pharmacological differentiation of metabotropic glutamate receptors coupled to potentiation of cyclic adenosine monophosphate responses and phosphoinositide hydrolysis. Winder DG, Smith T, Conn PJ (1993) J Pharmacol Exp Ther 266: 518-25 Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells. Kim SW, Beauchamp RD, Townsend CM, Thompson JC (1991) Surgery 110: 270-5; discussion 276 Cardiovascular effects of vasoactive intestinal peptide in healthy subjects. Frase LL, Gaffney FA, Lane LD, Buckey JC, Said SI, Blomqvist CG, Krejs GJ (1987) Am J Cardiol 60: 1356-61 Vasoactive intestinal peptide and substance P receptor antagonists improve postoperative ileus. Espat NJ, Cheng G, Kelley MC, Vogel SB, Sninsky CA, Hocking MP (1995) J Surg Res 58: 719-23
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.